← Browse by Condition
Medical Condition

acquired blepharophimosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06514612 Phase 3
Recruiting

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.

Enrollment
234 pts
Location
Czechia, France, Ger...
Sponsor
Santen SAS
View Trial →